Sign in to continue:

Thursday, February 26th, 2026

Diebold Nixdorf, Incorporated SEC Filing 8-K Document and Entity Information (2026)

Diebold Nixdorf, Inc. Files Form 8-K: Key Executive Changes and Corporate Updates

Diebold Nixdorf, Inc. (NYSE: DBD), a leading provider of calculating and accounting machines, has filed a Form 8-K with the Securities and Exchange Commission, disclosing significant updates that investors and shareholders should pay close attention to.

Key Points in the Report

  • Date of Report: February 24, 2026
  • Form Type: 8-K (Current Report)
  • Event Reported: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • Company Details: Diebold Nixdorf, Inc., incorporated in Delaware, headquartered at 350 Orchard Avenue NE, North Canton, OH 44720
  • Trading Symbol: DBD
  • Exchange: New York Stock Exchange (NYSE)
  • Emerging Growth Company Status: Diebold Nixdorf is not classified as an emerging growth company

Executive Appointment: Mr. Sesplankis Named Principal Accounting Officer

One of the most noteworthy items disclosed is the appointment of Mr. Sesplankis as the Principal Accounting Officer of Diebold Nixdorf, Inc. This change in executive leadership is crucial for shareholders, as the Principal Accounting Officer plays a vital role in overseeing the integrity and transparency of the company’s financial reporting.

  • Mr. Sesplankis receives an annual base salary, equity compensation, and an annual bonus as per company policies.
  • He is eligible for the standard employee benefits provided to all salaried employees.
  • Importantly, his compensation will remain unchanged following his designation as Principal Accounting Officer.
  • There are no related party transactions reportable under Item 5.02 of Form 8-K or Item 404(a) of Regulation S-K.
  • No arrangements or understandings with other persons led to his appointment.

Potential Price-Sensitive Information for Shareholders

  • Leadership Change: Executive changes at the accounting level can impact investor confidence, especially regarding financial controls and reporting. While the company states no change in compensation or related party issues, shareholders should monitor for any future impact on financial disclosures or audit practices.
  • No Emerging Growth Company Status: Diebold Nixdorf does not qualify as an emerging growth company. This means it is subject to the full range of SEC reporting and compliance requirements, and may not benefit from reduced regulatory burdens.
  • No Pre-Commencement Communications: The filing confirms that the company has not engaged in pre-commencement tender offers or soliciting material under relevant SEC rules. This indicates no imminent M&A activity or takeover events, which may reassure or disappoint investors seeking corporate action.

Securities Information

  • Registered Security: Common Stock, \$0.01 par value per share
  • Trading Symbol: DBD
  • Exchange: NYSE

Corporate Information

  • Business Address: 350 Orchard Avenue NE, North Canton, OH 44720
  • Business Phone: (330) 490-4000
  • Tax Identification Number: 34-0183970

Shareholder Considerations

  • Executive Stability: The transition appears orderly, with no changes to compensation or benefits. Investors should assess whether Mr. Sesplankis’ appointment signals continuity or a new direction for financial oversight.
  • Regulatory Compliance: Diebold Nixdorf remains subject to comprehensive SEC compliance, without emerging growth company exemptions. This may affect reporting costs and transparency.
  • No M&A Activity: The absence of tender offer or soliciting activity suggests no pending merger, acquisition, or restructuring.

Conclusion

The most price-sensitive information in this filing is the executive change at the Principal Accounting Officer level. While the company asserts that compensation and benefits are unchanged, such transitions can affect investor sentiment regarding governance and financial controls. Shareholders should stay alert for any subsequent disclosures or operational impacts.


Disclaimer: This article is provided for informational purposes only and does not constitute investment advice. Investors should conduct their own research and consult with financial professionals before making investment decisions. The information is based on Diebold Nixdorf, Inc.’s Form 8-K filing and may be subject to change.

View DIEBOLD NIXDORF, Inc Historical chart here



Eva Live, Inc. Enters Placement Agency and Securities Purchase Agreements with Maxim Group LLC and Streeterville Capital, LLC – SEC Filing Details

Eva Live Inc. Announces \$7.56 Million Secured Convertible Note Financing with Streeterville Capital, LLC Eva Live Inc. Announces \$7.56 Million Secured Convertible Note Financing with Streeterville Capital, LLC Los Angeles, CA – February 23,...

Green Brick Partners, Inc. 2025 Annual Report: Homebuilding, Land Development, and Market Strategies in Texas, Georgia, and Florida 27

Green Brick Partners, Inc. 2025 Annual Report: Key Highlights & Investor Analysis Green Brick Partners, Inc. (GRBK) 2025 Annual Report: Key Highlights & Investor Analysis Overview Green Brick Partners, Inc. (“Green Brick”, “the Company”)...

HCA Healthcare, Inc. 8-K Filing – 2026 Executive Officer Performance Excellence Program Details and Company Information

HCA Healthcare, Inc. Announces Executive Compensation Changes and Board Retirement in 8-K Filing HCA Healthcare, Inc. (“HCA” or “the Company”) has released a Form 8-K filing dated February 25, 2026, detailing significant developments that...

   Ad